← Back to headlines
Immix Stock Rises Following Bullish Morgan Stanley View on CAR-T Therapy
Immix shares have risen after Morgan Stanley initiated coverage with a bullish outlook on the company's CAR-T therapy, signaling positive investor sentiment.
25 Mar, 17:04 — 25 Mar, 17:04
Sources
Showing 1 of 1 sources
